Thurs.-Fri., Sept. 6-7, Mandarin Oriental, Washington, D.C.
ARLINGTON, Va., Aug. 30 /PRNewswire/ -- Three leading generic industry CEOs, along with top Wall Street analysts and key Food and Drug Administration (FDA) and other government officials, will headline the Generic Pharmaceutical Association's (GPhA) Annual Policy Conference on September 6-7, 2007. The conference, "Generics: Prescription for Affordable Health Care," will focus on the legislative, regulatory and business issues that will shape the generic industry in the coming years.
"This conference will look at the wide range of issues affecting the generic industry's efforts to provide consumers with timely access to affordable medicines," said Kathleen Jaeger, GPhA President and CEO. "From regulations to legislation, the industry is facing a series of unique opportunities and challenges."
The conference features keynote presentations from Hospira, Inc. Chairman and CEO Christopher Begley, Mylan Laboratories CEO Robert Coury, and Actavis President and CEO Robert Wessman.
Conference speakers also include U.S. Representatives Henry Waxman (D-CA) and Frank Pallone (D-NJ), FDA Deputy Commissioner Dr. Janet Woodcock, FDA Chief Counsel Sheldon Bradshaw, IMS Health Vice President Doug Long, UBS Warburg Healthcare Banking Director Tommy Erdei, Lehman Brothers Senior Vice President Richard Silver, and Roundtable Healthcare Partners Senior Partner David Koo, among other industry experts. In addition, the conference has special track sessions on federal legislation and legal issues, which will take place on September 6.
GPhA's Annual Policy Conference will be held at the Mandarin Oriental Hotel, 1330 Maryland Avenue, S.W., in Washington, D.C. The conference begins at 8 a.m. on both days. The conference agenda is available online at http://www.gphaonline.org.
Copyright©2007 PR Newswire.
All rights reserved